Literature DB >> 25698433

The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study.

Sanwei Guo1, Georg Müller, Kurt Lehmann, Scherwin Talimi, Gernot Bonkat, Heike Püschel, Thomas Gasser, Alexander Bachmann, Malte Rieken.   

Abstract

This study aims to compare long-term results of photoselective vaporization of the prostate (PVP) with an 80-W potassium titanyl phosphate (KTP) laser and monopolar transurethral resection of the prostate (TURP) in terms of efficacy, durability, and safety in an adjusted patient population. This prospective, non-randomized bi-center study included 120 (PVP) and 68 (TURP) patients in each arm. Patients were evaluated at 60 months of follow-up. Data from 30 (PVP) and 31 (TURP) patients were available for analysis. The primary outcome measurement was the International Prostate Symptom Score (IPSS) at 5 years. Secondary outcome measurements included voiding symptoms (quality of life (QoL) score), micturition parameters (maximal flow rate, Q max), post-void residual (PVR) volume, prostate-specific antigen (PSA) value, and reoperation rate. At study inclusion, voiding symptoms and micturition parameters were comparable between both groups. Age, prostate volume, and the proportion of patients with platelet aggregation inhibition or oral anticoagulation were significantly higher in the PVP group. No significant difference could be detected between patients available at 60 months and those lost to follow-up in terms of preoperative characteristics in either group. Sixty months postoperatively, the improvement of IPSS, QoL, Q max, and PVR volume showed no significant difference between both groups. PSA reduction was significantly higher after TURP. The reoperation rate due to urethral stricture (PVP, 13 %; TURP, none), bladder neck contracture (PVP, 3 %; TURP, none), and persisting or recurrent adenoma (PVP, 18 %; TURP, 3 %) was significantly higher after the 80-W PVP. Eighty-watt PVP leads to comparable functional outcomes to TURP. However, during a long-term follow-up, significantly more reoperations are necessary after PVP with the 80-W KTP laser, suggesting inferior tissue ablation capacity of the 80-W KTP laser.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25698433     DOI: 10.1007/s10103-015-1721-x

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  17 in total

1.  Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation.

Authors:  Robin Ruszat; Stephen Wyler; Thomas Forster; Oliver Reich; Christian G Stief; Thomas C Gasser; Tullio Sulser; Alexander Bachmann
Journal:  Eur Urol       Date:  2006-08-18       Impact factor: 20.096

2.  The effect of increased maximum power output on perioperative and early postoperative outcome in photoselective vaporization of the prostate.

Authors:  Malte Rieken; Gernot Bonkat; Georg Müller; Stephen Wyler; Nicole Ebinger Mundorff; Heike Püschel; Thomas Gasser; Alexander Bachmann
Journal:  Lasers Surg Med       Date:  2012-12-31       Impact factor: 4.025

3.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.

Authors:  Carlos Capitán; Cristina Blázquez; M Dolores Martin; Virginia Hernández; Enrique de la Peña; Carlos Llorente
Journal:  Eur Urol       Date:  2011-06-01       Impact factor: 20.096

4.  A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostate and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction: a single center experience.

Authors:  Anup Kumar; Pawan Vasudeva; Niraj Kumar; Biswajit Nanda; Sanjeev K Jha; Nayhan Mohanty
Journal:  J Endourol       Date:  2013-09-19       Impact factor: 2.942

5.  Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.

Authors:  Alexander Bachmann; Leander Schürch; Robin Ruszat; Stephen F Wyler; Hans-Helge Seifert; Alexander Müller; Kurt Lehmann; Tullio Sulser
Journal:  Eur Urol       Date:  2005-07-18       Impact factor: 20.096

Review 6.  Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.

Authors:  Sascha A Ahyai; Peter Gilling; Steven A Kaplan; Rainer M Kuntz; Stephan Madersbacher; Francesco Montorsi; Mark J Speakman; Christian G Stief
Journal:  Eur Urol       Date:  2010-06-11       Impact factor: 20.096

7.  Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.

Authors:  Robin Ruszat; Stephen F Wyler; Michael Seitz; Kurt Lehmann; Constanze Abe; Gernot Bonkat; Oliver Reich; Thomas C Gasser; Alexander Bachmann
Journal:  BJU Int       Date:  2008-07-29       Impact factor: 5.588

8.  GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.

Authors:  Robin Ruszat; Michael Seitz; Stephen F Wyler; Constanze Abe; Malte Rieken; Oliver Reich; Thomas C Gasser; Alexander Bachmann
Journal:  Eur Urol       Date:  2008-04-30       Impact factor: 20.096

Review 9.  Laser treatment of benign prostate enlargement--which laser for which prostate?

Authors:  Malte Rieken; Alexander Bachmann
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

10.  Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.

Authors:  Kaya Horasanli; Mesrur Selcuk Silay; Bulent Altay; Orhan Tanriverdi; Kemal Sarica; Cengiz Miroglu
Journal:  Urology       Date:  2008-02       Impact factor: 2.649

View more
  15 in total

1.  Five-year outcomes of thulium vapoenucleation of the prostate for symptomatic benign prostatic obstruction.

Authors:  A J Gross; A K Orywal; B Becker; C Netsch
Journal:  World J Urol       Date:  2017-04-12       Impact factor: 4.226

2.  [Long-term results after prostate vaporisation : GreenLight™ laser vaporisation of the prostate and electrovaporisation].

Authors:  M Rieken; A Bachmann; S F Shariat
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

3.  Transurethral resection of the prostate (TURP) vs GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up.

Authors:  S Cimino; S Voce; F Palmieri; V Favilla; T Castelli; S Privitera; R Giardina; G Reale; G I Russo; G Morgia
Journal:  Int J Impot Res       Date:  2017-08-17       Impact factor: 2.896

4.  GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine.

Authors:  Fei Luo; Hong-Hong Sun; Yan-Hui Su; Zhi-Hua Zhang; Ya-Shen Wang; Zhen Zhao; Jian Li
Journal:  Lasers Med Sci       Date:  2017-03-14       Impact factor: 3.161

Review 5.  Comparison of Patients Undergoing PVP Versus TURP for LUTS/BPH.

Authors:  Blake B Anderson; Joseph J Pariser; Brian T Helfand
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

Review 6.  Holmium Laser Enucleation of the Prostate: Patient Selection and Outcomes.

Authors:  Joseph M Kuebker; Nicole L Miller
Journal:  Curr Urol Rep       Date:  2017-10-19       Impact factor: 3.092

Review 7.  Bladder Neck Contracture After Endoscopic Surgery for Benign Prostatic Obstruction: Incidence, Treatment, and Outcomes.

Authors:  Giulia Primiceri; Pietro Castellan; Michele Marchioni; Luigi Schips; Luca Cindolo
Journal:  Curr Urol Rep       Date:  2017-08-09       Impact factor: 3.092

8.  Reasons to believe in vaporization: a review of the benefits of photo-selective and transurethral vaporization.

Authors:  Russell N Schwartz; Felix Couture; Iman Sadri; Adel Arezki; David-Dan Nguyen; Ahmed S Zakaria; Kyle Law; Dean Elterman; Malte Rieken; Hannes Cash; Kevin C Zorn
Journal:  World J Urol       Date:  2020-09-15       Impact factor: 4.226

9.  Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: Five-year experience of safety, efficiency, and functional outcomes.

Authors:  Khaled Ajib; Mila Mansour; Marc Zanaty; Mansour Alnazari; Pierre-Alain Hueber; Malek Meskawi; Roger Valdivieso; Come Tholomier; Benjamin Pradere; Vincent Misrai; Dean Elterman; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2018-03-19       Impact factor: 1.862

10.  Photoselective sharp enucleation of the prostate with a front-firing 532-nm laser: an innovative surgical technique for benign prostatic hyperplasia-a single-center study of 475 cases.

Authors:  Yongquan Wang; Zhengchao Liu; Tao Jiang; Xiaozhou Zhou; Zhipeng Chen; Jun Zheng; Dishi Yan; Yuanxiu Zhou; Zhansong Zhou; Wenhao Shen
Journal:  World J Urol       Date:  2021-01-03       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.